MedPath

Functional MR Lung Imaging Using Hyperpolarised 129Xe

Completed
Conditions
IPF
COPD
Registration Number
NCT02976935
Lead Sponsor
University of Nottingham
Brief Summary

The aim of this study is to investigate the potential value of a novel imaging technique (hyperpolarized 129Xe lung imaging) in the diagnosis and assessment of lung disease in patients with COPD and IPF.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
53
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acquisition of baseline data and images to investigate use of hp129Xe as a diagnostic tool4 years

i) Obtain baseline data for each group with matched clinical data (e.g. pulmonary function tests) allowing comparison with existing clinical diagnostic techniques and also determining correlation with disease severity ii) Use the images obtained to set up standard sequencing protocols and define algorithms and inform power calculations for subsequent studies

Secondary Outcome Measures
NameTimeMethod
Collation of data regarding ability of participants to adhere to the study protocol4 years

1) To collate data regarding the ability of participants of each group to adhere to the protocol thus informing the study design of future trials.

Trial Locations

Locations (1)

Hyperpolarised Imaging Lung Facility, QMC, Uni of Nottingham

🇬🇧

Nottingham, United Kingdom

Hyperpolarised Imaging Lung Facility, QMC, Uni of Nottingham
🇬🇧Nottingham, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.